<div class="accordion" id="accordionExample">
  <!-- Item 1 -->
  <div class="accordion-item">
    <h2 class="accordion-header">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseOne" aria-expanded="true" aria-controls="collapseOne">
        Sepsis
      </button>
    </h2>
    <div id="collapseOne" class="accordion-collapse collapse" data-bs-parent="#accordionExample">
      <div class="accordion-body">
        <p>
    When to suspect sepsis:
</p>
<ul>
    <li data-list-item-id="eb1e0aeef85c5a9d2add2e598af672b72">
         Post-op fever
    </li>
    <li data-list-item-id="eaba69ffaf808651407aa9b0ee72996eb">
         Organ dysfunction or Suspected Infection
    </li>
    <li data-list-item-id="e436047d04c870724ba0e60a1a68229b5">
         Positive SIRS or qSOFA
    </li>
</ul>

<p>
    Empiric approach:
</p>
<ul>
    <li data-list-item-id="e14736305e8863aae09d63f85cf2c5d24">
         Unknown source → Tazocin 4.5 g IV q8h or Meropenem 1 g IV q8h (+ Vancomycin if indicated)
    </li>
    <li data-list-item-id="e8e5e57a77b7767ab624aa25af863221d">
         History/colonization with VRE → swap Vancomycin for Daptomycin 6 mg/kg IV q24h&nbsp;
    </li>
</ul>
      </div>
    </div>
  </div>

  <!-- Item 2 -->
  <div class="accordion-item">
    <h2 class="accordion-header">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo">
        Bacterial Infections
      </button>
    </h2>
    <div id="collapseTwo" class="accordion-collapse collapse" data-bs-parent="#accordionExample">
      <div class="accordion-body">
        <p>
    <strong>Bloodstream Infections:</strong>
</p>
<ul>
    <li data-list-item-id="e9a1293e1ddbf0060f900dea850ef52f6">
         Gram positive:
        <ul>
            <li data-list-item-id="eaa636160e9b1a22e13b5d37d4c81b784">
                 Vancomycin 1 g IV q12h OR daptomycin 6 mg/kg IV q24h if VRE history
            </li>
            <li data-list-item-id="e4f0ccd68d4de91da5a139bcb12e37902">
                 Duration: 2 wks after negative cultures
            </li>
            <li data-list-item-id="e2c69873fff425a445dce42a4acf05ca0">
                 If complicated (endocarditis, osteomyelitis): 4–6 wks
            </li>
        </ul>
    </li>
    <li data-list-item-id="ee1e9b14801262c79463ef58a083676a2">
         Gram negative:
        <ul>
            <li data-list-item-id="e2476ab302e234e0a084a2ce7913d2910">
                 Piptazo 4.5 g IV q8h OR meropenem 1 g IV q8h
            </li>
            <li data-list-item-id="e3d4fe2fdebcdc09e05c33bda781c6ca1">
                 Duration: 2 wks
            </li>
        </ul>
    </li>
</ul>
<p>
    <strong>Central Line Infection:</strong>
</p>
<ul>
    <li data-list-item-id="e1e7c756f2ddb7e7aaedd5d630210f96b">
         Remove line if:
        <ul>
            <li data-list-item-id="ee0aaf377f33cebf3eb8d970b8424bdf9">
                 Candida spp., Mycobacteria spp., S. aureus, S. lugdunensis, P. aeruginosa
            </li>
            <li data-list-item-id="e074252528a2b39bd01420e0f65ac90fb">
                 Persistent positive cultures &gt;72h
            </li>
            <li data-list-item-id="eba7323fc232879c3efb5c3e07f1fdb84">
                 Signs of infection despite antibiotics
            </li>
            <li data-list-item-id="e5c78a3c6b195e0a72070c5ce82c2ca51">
                 Complications: septic thrombophlebitis, endocarditis, osteomyelitis
            </li>
            <li data-list-item-id="e3efdf146bf95ee1d47f569979aad8997">
                 Extensive cellulitis (&gt;2 cm)
            </li>
            <li data-list-item-id="eb2dcbc06ed7f9b9e77cd677301617315">
                 Relapsed infection post-treatment
            </li>
        </ul>
    </li>
    <li data-list-item-id="ea5abef71e21b23385e70658245395eb8">
         If persistent after removal then investigate with ECHO, CT chest/abdo/pelvis
    </li>
</ul>
<p>
    <strong>Intra-Abdominal Infection:</strong>
</p>
<ul>
    <li data-list-item-id="ee6be8e26274f0780bb3a91c3d0c89596">
         Work-up: CT abdomen/pelvis
    </li>
    <li data-list-item-id="eee23008450eadf8d46558ca8f0f28c90">
         Empiric:
        <ul>
            <li data-list-item-id="e1bf4fd5ac5fc1ae31bda7da06a953c84">
                 Hx pseudomonas: Piptazo 4.5 g IV q8h or meropenem 1 g IV q8h + vancomycin 1 g IV q12h (daptomycin if VRE)
            </li>
            <li data-list-item-id="e7d518932e0ba0eb487327efe7ada6695">
                 No pseudomonas: ertapenem 1 g IV q24h + vancomycin 1 g IV q12h (or dapto if VRE)
            </li>
        </ul>
    </li>
</ul>
<p>
    <strong>C. difficile:</strong>
</p>
<ul>
    <li data-list-item-id="e608f32d7c936af0db97ebffd07423478">
         Mild: vanco 125 mg PO QID × 10 days
    </li>
    <li data-list-item-id="e296b5b30fa0b1ad1b7931dcea7b26daf">
         Severe: vanco 500 mg PO QID + metronidazole 500 mg IV q8h + vanco 500 mg enema QID × 14 days
    </li>
    <li data-list-item-id="ec3c14682a3d1c15f914d957e598c6e97">
         Recurrence:
        <ul>
            <li data-list-item-id="eb48206f5afe58f5532b7afed75d5e8e7">
                 1st: vanco 125 mg PO QID × 10 days → taper regimen
            </li>
            <li data-list-item-id="e7bdf310d6a300f71b4b46185abce649c">
                 2nd: same + consider fecal transplant
            </li>
        </ul>
    </li>
</ul>
<p>
    <strong>Urinary Tract Infection (UTI)</strong>
</p>
<ul>
    <li data-list-item-id="e04bc2be703042e620ed4b29eded46e47">
         Do not treat if asymptomatic and no recent kidney transplant (&lt;2 months) or stent in place.
    </li>
    <li data-list-item-id="ebc7a56ac83c2e047193e1414ee978813">
         Empiric treatment:
    </li>
    <li data-list-item-id="ef9a519ed458d46d895f84b6b74b59c55">
         Ceftriaxone 1 g IV q24h — 7 days for cystitis, 14–21 days for pyelonephritis.
    </li>
    <li data-list-item-id="e1442508d10033ec9cd01c1cf2df5f81d">
         If recent kidney transplant (&lt;2 months) or stent in place: Ertapenem 1 g IV q24h + Daptomycin 6 mg/kg IV q24h if history of VRE.
    </li>
    <li data-list-item-id="edb379549e41629b272f6a3e8eab7906d">
         Adjust antibiotics based on culture susceptibilities.&nbsp;
    </li>
</ul>
      </div>
    </div>
  </div>

  <!-- Item 3 -->
  <div class="accordion-item">
    <h2 class="accordion-header">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseThree" aria-expanded="false" aria-controls="collapseThree">
        Pneumonia
      </button>
    </h2>
    <div id="collapseThree" class="accordion-collapse collapse" data-bs-parent="#accordionExample">
      <div class="accordion-body">
        <ul>
    <li data-list-item-id="e12b9073373e27f7b81e5f702bc00b5c2">
         Admit if: O₂ need, qSOFA+, multifocal pneumonia
    </li>
    <li data-list-item-id="e3c1debe7e83569fbbbb1544d2a642721">
         Empiric:
        <ul>
            <li data-list-item-id="e29f3e2191d46fd66ba1c95a2faf52d22">
                 CAP: ceftriaxone 1 g IV q24h + azithromycin 500 mg PO daily × 5–7 days
            </li>
            <li data-list-item-id="e08d88a71d91d7ce88bce7ea44620206e">
                 HCAP/VAP: Piptazo + azithromycin
            </li>
        </ul>
    </li>
</ul>
<p>
    Target organism:&nbsp;
</p>
<figure class="table">
<table class="table table-bordered">         <tbody>             <tr class="table-secondary">
                <td>
                    <strong>Organism&nbsp;</strong>
                </td>
                <td>
                    <strong>Treatment&nbsp;</strong>
                </td>
                <td>
                    <strong>Duration&nbsp;</strong>
                </td>
            </tr>
            <tr>
                <td>
                    <strong>COVID-19&nbsp;</strong>
                </td>
                <td>
                    Mild: Sotrovimab 500 mg IV (or Paxlovid 3 tabs PO BID if IV contraindicated)Moderate (O₂): Dexamethasone 6 mg PO/IV + Remdesivir 200 mg IV day 1, 100 mg IV day 4Severe (ICU): Dexamethasone + Tocilizumab 8 mg/kg IV (max 800 mg)&nbsp;
                </td>
                <td>
                    <p>
                        Sotrovimab: 1 dose
                    </p>
                    <p>
                        Paxlovid: 5 days
                    </p>
                    <p>
                        Dexamethasone: until off O₂
                    </p>
                    <p>
                        Tocilizumab: 1–2 doses if no improvement&nbsp;
                    </p>
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Influenza&nbsp;</strong>
                </td>
                <td>
                    Tamiflu 75 mg PO BID (150 mg BID if severe/poor response)&nbsp;
                </td>
                <td>
                    ≥5 days or until symptom resolution&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Parainfluenza&nbsp;</strong>
                </td>
                <td>
                    Supportive care if mild Ribavirin 15–20 mg/kg/day if severe/not improving&nbsp;
                </td>
                <td>
                    7–10 days or until resolution&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Human Metapneumovirus&nbsp;</strong>
                </td>
                <td>
                    Supportive care if mild Ribavirin if severe/not improving&nbsp;
                </td>
                <td>
                    7–10 days or until resolution&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>RSV&nbsp;</strong>
                </td>
                <td>
                    Supportive care if URTI Ribavirin if pneumonia or persistent URTI&nbsp;
                </td>
                <td>
                    7–10 days or until resolution&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Adenovirus&nbsp;</strong>
                </td>
                <td>
                    Cidofovir 5 mg/kg/week × 2 wks → then q2w&nbsp;
                </td>
                <td>
                    Until resolution&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>S. pneumoniae&nbsp;</strong>
                </td>
                <td>
                    Ceftriaxone 1 g IV daily&nbsp;
                </td>
                <td>
                    5–7 days&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Legionella&nbsp;</strong>
                </td>
                <td>
                    Azithromycin 500 mg PO/IV daily&nbsp;
                </td>
                <td>
                    3 weeks&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>PCP&nbsp;</strong>
                </td>
                <td>
                    Septra 15 mg/kg/day then prophylaxis dose ± IV pentamidine 4 mg/kg/day; Prednisone taper if PaO₂ &lt; 70 or A–a ≥ 35 mmHg&nbsp;
                </td>
                <td>
                    2–3 wks treatment; 1 yr prophylaxis&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Histoplasma&nbsp;</strong>
                </td>
                <td>
                    Amphotericin B 3 mg/kg/day × 2 wks → Itraconazole 200 mg PO BID × 12 mo → Fluconazole 200 mg PO daily (lifelong prophylaxis)&nbsp;
                </td>
                <td>
                    2 wks + 12 mo + lifelong prophylaxis&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Coccidioidomycosis&nbsp;</strong>
                </td>
                <td>
                    Amphotericin B 5 mg/kg/day × 2 wks → Fluconazole 400 mg PO BID × 12 mo → Fluconazole 200 mg PO daily (lifelong prophylaxis)&nbsp;
                </td>
                <td>
                    2 wks + 12 mo + lifelong prophylaxis&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Blastomycosis&nbsp;</strong>
                </td>
                <td>
                    Amphotericin B 5 mg/kg/day × 2 wks → Itraconazole 200 mg PO BID × 12 mo&nbsp;
                </td>
                <td>
                    2 wks + 12 mo&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Aspergillus&nbsp;</strong>
                </td>
                <td>
                    Voriconazole 6 mg/kg IV q12h × 1 day → 4 mg/kg IV q12h&nbsp;
                </td>
                <td>
                    12 wks or until clinical/radiologic improvement&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>TB&nbsp;</strong>
                </td>
                <td>
                    Isoniazid + Rifampin + Pyrazinamide + Ethambutol + Pyridoxine × 2 mo → Isoniazid + Rifampin&nbsp;
                </td>
                <td>
                    2 mo + 9–12 mo&nbsp;
                </td>
            </tr>
        </tbody>
    </table>
</figure>
      </div>
    </div>
  </div>

  <!-- Item 4 -->
  <div class="accordion-item">
    <h2 class="accordion-header">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseFour" aria-expanded="false" aria-controls="collapseFour">
        Fungal Infections
      </button>
    </h2>
    <div id="collapseFour" class="accordion-collapse collapse" data-bs-parent="#accordionExample">
      <div class="accordion-body">
        <p>
    <strong>Candidemia</strong>
</p>
<ul>
    <li data-list-item-id="e5c00623051b81f4003aaf1432c5f4e16">
         Remove central line
    </li>
    <li data-list-item-id="e7e4820edd7fa14477b0eb7a12e0c9a51">
         Daily blood cultures, ECHO, CT abdomen/pelvis, ophtho consult
    </li>
    <li data-list-item-id="e619dcf13a858735728f4eaf15d18b3d4">
         Treatment:
        <ul>
            <li data-list-item-id="e7667324ab0f65b80b4e4d3dddb24725b">
                 On fluconazole prophylaxis/resistant: micafungin 100 mg IV daily
            </li>
            <li data-list-item-id="e4a60de9f6b3f615cdb3c9f41a7978609">
                 Otherwise: fluconazole 800 mg load, then 400 mg daily
            </li>
        </ul>
    </li>
    <li data-list-item-id="e99bf4be7475fccad518c9756886ee3bb">
         Duration: 2 wks after negative cultures if no complications
    </li>
</ul>
<p>
    <strong>Candiduria:</strong>
</p>
<ul>
    <li data-list-item-id="e57ac63ee59e6c97229b22964effbd642">
         Do not treat if asymptomatic and no upcoming urological procedure.
    </li>
    <li data-list-item-id="e65566ffe21c67cddb1f787c053cc9ba4">
         If symptomatic → remove stent or exchange Foley catheter, order renal ultrasound to rule out abscess or fungal mass.
    </li>
    <li data-list-item-id="ef7b49964d8432b77a8e25958097cf378">
         Treat with Fluconazole 400 mg IV/PO daily × 7–14 days, or Micafungin 100 mg IV daily × 7–14 days if resistant/allergic to fluconazole.
    </li>
</ul>
<p>
    <strong>Histoplasma</strong>
</p>
<ul>
    <li data-list-item-id="e668b42b50a94d8a04a245004f61b86f2">
         Severe: amphotericin B 3 mg/kg/day × 2 wks
    </li>
    <li data-list-item-id="e0d1e3d54b74ec156f0d9069671983020">
         Then itraconazole 200 mg PO bid × 12 mo
    </li>
    <li data-list-item-id="e4372322553bc8951dcf25a1d348614f2">
         Lifelong fluconazole 200 mg daily prophylaxis
    </li>
</ul>
<p>
    <strong>Coccidioidomycosis</strong>
</p>
<ul>
    <li data-list-item-id="ece16cb9d4a54715dbda268c7e5e97a39">
         Severe: amphotericin B 5 mg/kg/day × 2 wks
        <ul>
            <li data-list-item-id="eb0fcdf6f93d656db5b4b2060fe61818a">
                 Then fluconazole 400 mg PO bid × 12 mo
            </li>
        </ul>
    </li>
    <li data-list-item-id="e8e386443779d04327856135d5771105e">
         Lifelong fluconazole 200 mg daily prophylaxis
    </li>
</ul>
<p>
    <strong>Blastomycosis</strong>
</p>
<ul>
    <li data-list-item-id="e13cac9c6a5dd53e039bc0729322852c9">
         Severe: amphotericin B 5 mg/kg/day × 2 wks
    </li>
    <li data-list-item-id="ea012c347498493612a0a642a0135fbf5">
         Then itraconazole 200 mg PO bid × 12 mo
    </li>
    <li data-list-item-id="e6feabaf1c8a935862bc1147e763e4074">
         No long-term prophylaxis
    </li>
</ul>
<p>
    <strong>Aspergillus</strong>
</p>
<ul>
    <li data-list-item-id="e3cfb128353128817da06b38f4d2836f5">
         Voriconazole 6 mg/kg IV q12h × 1 day
        <ul>
            <li data-list-item-id="ef85f8b177c4c637f40dbbeeb98356754">
                 Followed by 4 mg/kg IV q12h × 12 wks or until resolution&nbsp;
            </li>
        </ul>
    </li>
</ul>
      </div>
    </div>
  </div>

  <!-- Item 5 -->
  <div class="accordion-item">
    <h2 class="accordion-header">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseFive" aria-expanded="false" aria-controls="collapseFive">
        Viral Infections
      </button>
    </h2>
    <div id="collapseFive" class="accordion-collapse collapse" data-bs-parent="#accordionExample">
      <div class="accordion-body">
        <p>
    <strong>CMV</strong>
</p>
<ul>
    <li data-list-item-id="e91dace100927119f9c0769b03067a28c">
         Asymptomatic infection: valganciclovir 900 mg PO daily until PCR negative
    </li>
    <li data-list-item-id="e68ad2c9320853e8f2147aa75c6d098b9">
         CMV syndrome: valganciclovir 900 mg PO bid × 2–3 wks → daily × 3–8 wks until PCR negative for 2 wks
    </li>
    <li data-list-item-id="e5ed91d41f0c9c4d9336c924171d5de0f">
         Invasive disease: ganciclovir 5 mg/kg IV bid × 2–3 wks → valganciclovir daily × 3–8 wks until PCR negative for 2 wks
    </li>
    <li data-list-item-id="e973376f8d17508ea3d5c19ba3e34d2d1">
         Resistant CMV: foscarnet or cidofovir ± Cytogam; see mutation-specific guidance
    </li>
</ul>
<p>
    <strong>HSV</strong>
</p>
<ul>
    <li data-list-item-id="ef42ea2cd09f31bd9c0456da2c0b0a0eb">
         Mucocutaneous: acyclovir 400 mg PO q8h × 5–7 days or until healed
    </li>
    <li data-list-item-id="e378f94676ffb98971d463cffebab878c">
         Severe/CNS: acyclovir 10 mg/kg IV q8h × 3 wks
    </li>
    <li data-list-item-id="e7221c875a5de9264bdfaeffa8353149f">
         Keratitis: topical ganciclovir 0.15% Q2h ± acyclovir PO&nbsp;
    </li>
</ul>
      </div>
    </div>
  </div>

  <!-- Item 6 -->
  <div class="accordion-item">
    <h2 class="accordion-header">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseSix" aria-expanded="false" aria-controls="collapseSix">
        Parasitic Infections
      </button>
    </h2>
    <div id="collapseSix" class="accordion-collapse collapse" data-bs-parent="#accordionExample">
      <div class="accordion-body">
        <p>
    <strong>Toxoplasmosis</strong>
</p>
<ul>
    <li data-list-item-id="e9632eb023561b08e58d0864f16728a59">
         Induction: pyrimethamine 200 mg PO once → 75 mg PO daily + sulfadiazine 1.5 g PO q6h + leucovorin 25 mg PO daily × 6 wks
    </li>
    <li data-list-item-id="e8f2bce8f36cf0fcee76279f69c3d246e">
         Maintenance: pyrimethamine 50 mg PO daily + sulfadiazine 4 g PO daily + leucovorin 25 mg PO daily × 12 mo
    </li>
    <li data-list-item-id="ec83418ac842ac208118426bc6d42746f">
         Lifelong Septra M/W/F prophylaxis&nbsp;
    </li>
</ul>
      </div>
    </div>
  </div>

  <!-- Item 7 -->
  <div class="accordion-item">
    <h2 class="accordion-header">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseSeven" aria-expanded="false" aria-controls="collapseSeven">
        Tissue/CNS/Bone Related
      </button>
    </h2>
    <div id="collapseSeven" class="accordion-collapse collapse" data-bs-parent="#accordionExample">
      <div class="accordion-body">
        <p>
    <strong>Cellulitis</strong>
</p>
<ul>
    <li data-list-item-id="e5a19d6450c81aed061856a6136b884d8">
         Uncomplicated (no abscess): Cephalexin 500 mg PO q6h × 5–7 days.
    </li>
    <li data-list-item-id="e73c1737707d1dc26deccb2159e644b40">
         If MRSA suspected/confirmed: Septra DS PO BID × 5–7 days.
    </li>
    <li data-list-item-id="ed636452262c3cd2fa36afaa063502d7a">
         Complicated (abscess or requiring admission): Cefazolin 1 g IV q8h × 7–10 days OR Vancomycin 15 mg/kg IV q12h × 7–10 days.
    </li>
    <li data-list-item-id="e900ef86d7f3d52b223e388ff0dcc2f57">
         If no improvement → consider Pseudomonas (ciprofloxacin PO or piptazo IV) or fungal cause (skin biopsy + fluconazole/micafungin).
    </li>
</ul>
<p>
    <strong>Septic Arthritis</strong>
</p>
<ul>
    <li data-list-item-id="ebba4962e2158ffa4143874bb1f085fe0">
         All cases require joint aspiration and orthopedic consult.
    </li>
    <li data-list-item-id="ea25cc601b66af1bade4a56c17ac80b90">
         Empiric treatment: Ceftriaxone 2 g IV q24h OR Piptazo 4.5 g IV q8h + Vancomycin 15 mg/kg IV q12h.
    </li>
    <li data-list-item-id="e4c8f207be42aafdf71fbc54e6e4643c4">
         Targeted therapy:
        <ul>
            <li data-list-item-id="e4a4580e589cccf7580cccf8d3370b2df">
                 MSSA → Cefazolin 2 g IV q8h × 4 weeks.
            </li>
            <li data-list-item-id="e482831802e80326af112dc3382a3ab30">
                 MRSA → Vancomycin 15 mg/kg IV q12h × 4 weeks.
            </li>
            <li data-list-item-id="ef1b6a2d099efd4642df6c2f2c55b2159">
                 Gonorrhea → Ceftriaxone 2 g IV q24h × 7–10 days.
            </li>
        </ul>
    </li>
</ul>
<p>
    <strong>Osteomyelitis</strong>
</p>
<ul>
    <li data-list-item-id="e83d7dd1edbaa153a55d0baf7712ef9ae">
         Always obtain sterile deep tissue cultures (percutaneous or surgical) and involve ortho/wound care.
    </li>
    <li data-list-item-id="e7bdfc485db3f61e51d7de54407e20652">
         Empiric treatment:
        <ul>
            <li data-list-item-id="e5b245423ea68f35f1405f9747d15710c">
                 Ceftriaxone 2 g IV q24h + Vancomycin 15 mg/kg q12h ± Metronidazole 500 mg q12h (if sacral involvement).
            </li>
            <li data-list-item-id="e2444753606ea4e7ca0f7dee153ff93db">
                 If ESBL history → Meropenem 1 g IV q8h + Vancomycin.
            </li>
        </ul>
    </li>
    <li data-list-item-id="e67b4c624514d714986f0af48888ae06d">
         Targeted therapy:
        <ul>
            <li data-list-item-id="e6b6e31c88d3f4dceb8d4aaac4afeab17">
                 MSSA → Cefazolin 2 g IV q8h × 6 weeks.
            </li>
            <li data-list-item-id="edfa0f243824662347f5526b1dd246058">
                 MRSA → Vancomycin 15 mg/kg IV q12h × 6 weeks.
            </li>
            <li data-list-item-id="ef6ce5e8141dc17e60d068eb08e79c7ff">
                 E. coli/Klebsiella → Ceftriaxone 2 g IV q24h × 6 weeks.
            </li>
            <li data-list-item-id="e5691038eb122804531f5fda2c87506f6">
                 ESBL → Meropenem 1 g IV q8h × 6 weeks.
            </li>
        </ul>
    </li>
</ul>
<p>
    <strong>Diabetic Foot Infection</strong>
</p>
<ul>
    <li data-list-item-id="e2831f998d25c7da1c2ee2bb076ea1f63">
         Always assess vascular supply with ultrasound.
    </li>
    <li data-list-item-id="ee1da5a2b9c16706442e0bf882d678245">
         Mild infection (localized cellulitis &lt;2 cm, superficial wound): Cephalexin 500 mg PO q6h × 7–14 days OR Septra DS BID × 7–14 days (if MRSA risk).
    </li>
    <li data-list-item-id="ecc273afc2bc8d14791853a279a6aa34b">
         Moderate infection (cellulitis &gt;2 cm, deeper involvement, purulence): Ceftriaxone 1 g IV q24h + Metronidazole 500 mg q12h ± Vancomycin (if MRSA risk).
    </li>
    <li data-list-item-id="e40aa4249bf2c67cdc4dbbd9640c93aac">
         Severe infection (necrosis, gangrene, hemodynamic instability, sepsis): Piptazo 4.5 g IV q8h OR Meropenem 1 g IV q8h (if ESBL) + Vancomycin 15 mg/kg q12h.
    </li>
</ul>
<p>
    <strong>Meningitis / CNS Infections</strong>
</p>
<ul>
    <li data-list-item-id="ec9fd5317fd21c1599c3aaf620e660584">
        <strong> Pre-LP Requirement</strong>: Always perform CT brain before lumbar puncture.
    </li>
    <li data-list-item-id="e1226a12ae5b4b868e380f46b15fdf925">
         <strong>Empiric Treatment</strong>: Ceftriaxone 2 g IV q12h + Vancomycin (25 mg/kg IV loading, then 15 mg/kg q8h) + Ampicillin 2 g IV q4h + Acyclovir 10 mg/kg IV q8h.
    </li>
    <li data-list-item-id="ef90a5268643a139b19fcc343a083bfcc">
         <strong>Organism-Specific</strong>:
        <ul>
            <li data-list-item-id="efe84a3e69c57719073b750e60b5bda95">
                 S. pneumoniae: Ceftriaxone ± Vancomycin (if penicillin-resistant) × 2 wks.
            </li>
            <li data-list-item-id="e94dd66aa011bb008db9aebdb5a40a225">
                 N. meningitidis: Ceftriaxone × 1 wk.
            </li>
            <li data-list-item-id="e15cabf37fb1b04302fad21d7f1f348ef">
                 Listeria: Ampicillin × 3 wks, then Septra prophylaxis × 1 yr.
            </li>
            <li data-list-item-id="efb407349a1b1ca54f80b8492fe3b2b5d">
                 HSV: Acyclovir × 3 wks.
            </li>
            <li data-list-item-id="eb25903d530ae5761c5323e0436580b5f">
                 West Nile Virus: Ribavirin × 3 wks + IVIG × 5 days.
            </li>
            <li data-list-item-id="ec24f3f97c67029149d5d473e9155e36d">
                 Invasive Fungal: Amphotericin B + Voriconazole until resolved.
            </li>
            <li data-list-item-id="e1f1a1fe4bb6ddc4ee41b517249673e9d">
                 Cryptococcus: Amphotericin B + Flucytosine × 2 wks → Fluconazole BID × 8 wks → Fluconazole daily × 12 mo.
            </li>
            <li data-list-item-id="ef385648211df0244c2c0e200baabb7ec">
                 Toxoplasmosis: Pyrimethamine + Sulfadiazine + Leucovorin × 6 wks → maintenance × 12 mo → Septra prophylaxis lifelong.
            </li>
        </ul>
    </li>
</ul>
<p>
    <strong>Endocarditis</strong>
</p>
<ul>
    <li data-list-item-id="e466ea89414d36a4791fc79134ed5190d">
        <strong> Initial Steps</strong>: Obtain 3 sets of blood cultures 1 hr apart before starting antibiotics.
    </li>
    <li data-list-item-id="ec74cb3d92c4d36b28f8bab6bf53714ed">
        <strong> Empiric Treatment</strong>: Ceftriaxone 2 g IV q24h + Vancomycin 15 mg/kg IV q12h.
    </li>
    <li class="ck-list-marker-bold" data-list-item-id="eeadce42d67ad0f7cd13bbe5ee728cdad">
        <strong> Organism-Specific:</strong>
        <ul>
            <li data-list-item-id="e07c631ae5f51cb4a2320bb396489f44c">
                 MSSA:
                <ul>
                    <li data-list-item-id="eb021c84eec14b780ecbeb39c852aabd0">
                         Native: Cloxacillin or Cefazolin × 6 wks.
                    </li>
                    <li data-list-item-id="ec96b3be30c5e61d63af472115c68b41a">
                         Prosthetic: Cloxacillin + Rifampin × 6 wks + Gentamicin × 2 wks.
                    </li>
                </ul>
            </li>
            <li data-list-item-id="e97c4dcd8c2988fc2d7da0936260f400b">
                 MRSA:
                <ul>
                    <li data-list-item-id="ee20985e9a6aec3aaf7700538fa259dbc">
                         Native: Vancomycin × 6 wks.
                    </li>
                    <li data-list-item-id="ed7b99932de857cbb63c1c3a08513d8cf">
                         Prosthetic: Vancomycin + Rifampin × 6 wks + Gentamicin × 2 wks.
                    </li>
                </ul>
            </li>
            <li data-list-item-id="e4b070902fa28e90eb7025480ebbb0176">
                 Strep viridans:
                <ul>
                    <li data-list-item-id="ec085cbacec46c71072116edc8c1d4f08">
                         Native: Ceftriaxone × 4 wks.
                    </li>
                    <li data-list-item-id="ec11d3e28e4b5d826275a369f5a7b88e7">
                         Prosthetic: Ceftriaxone × 6 wks + Gentamicin × 2 wks.
                    </li>
                </ul>
            </li>
            <li data-list-item-id="ef3d0ea7418e6e29222eeac6107063db3">
                 Enterococci: Ampicillin + Ceftriaxone or Vancomycin × 6 wks.
            </li>
            <li data-list-item-id="ef9de996c544e8b1bc098cfca7ae4055c">
                 HACEK: Ceftriaxone × 4 wks (native) or × 6 wks (prosthetic).&nbsp;
            </li>
        </ul>
    </li>
</ul>
      </div>
    </div>
  </div>

  <!-- Item 8 -->
  <div class="accordion-item">
    <h2 class="accordion-header">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseEight" aria-expanded="false" aria-controls="collapseEight">
        T-cell Mediated Rejection
      </button>
    </h2>
    <div id="collapseEight" class="accordion-collapse collapse" data-bs-parent="#accordionExample">
      <div class="accordion-body">
        <figure class="table">
<table class="table table-bordered">         <tbody>             <tr class="table-secondary">
                <td>
                    <strong>Mild Rejection (RAI 3–4)&nbsp;</strong>
                </td>
                <td>
                    <strong>Moderate–Severe (RAI 5–9)&nbsp;</strong>
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Outpatient management&nbsp;</strong>
                </td>
                <td>
                    <strong>Inpatient management&nbsp;</strong>
                </td>
            </tr>
            <tr>
                <td>
                    <ul>
                        <li data-list-item-id="e6cb6f6f89f2e02404e1e822829c9146c">
                              Increase prednisone to 20–40 mg PO daily × 2–4 wks and then taper
                        </li>
                        <li data-list-item-id="e07e79054f3e99a85e48855d2a07c8995">
                             Increase tacrolimus (trough 8–12)
                        </li>
                        <li data-list-item-id="e8b84bfa06d5e299df236e0edf87188e0">
                             Add myfortic 540–720 mg PO bid
                        </li>
                        <li data-list-item-id="eacb12d4eb2dfbcf0c600dd975c3b6617">
                             LFTs twice weekly&nbsp;
                        </li>
                    </ul>
                </td>
                <td>
                    <ul>
                        <li data-list-item-id="eed8209336b789f3c2536fc5c952a1452">
                              Methylprednisolone 500 mg IV daily × 3 days &nbsp;
                        </li>
                        <li data-list-item-id="e983be334daf20d054843ce797da2f834">
                             Prednisone PO taper
                        </li>
                        <li data-list-item-id="ed392be33aee5d61ac2cf223cacc291aa">
                             Consider additional 2 days IV if partial response
                        </li>
                        <li data-list-item-id="e7a3de90689c8854629e1e07aae078007">
                             Increase tacrolimus, add myfortic
                        </li>
                        <li data-list-item-id="e09d5d6a3188360bbf5275cd9508f4f2c">
                             ATG 5–6 mg/kg over 4–7 days (target WBC &lt;0.2)
                        </li>
                        <li data-list-item-id="e09865bfae22d0cf2751c7615e0b55b03">
                             Repeat biopsy after ATG; send for DSA, C4D staining
                        </li>
                        <li data-list-item-id="e61684a914cb2d769f56462d2cd0a0170">
                             Plasmapheresis daily or q48h × 5–7 days (replace with FFP) + IVIG pre/post
                        </li>
                        <li data-list-item-id="edeaf31a6a534aad08d2310dc3b400a82">
                             Rituximab 375 mg/m² IV weekly × 1–2 doses
                        </li>
                        <li data-list-item-id="ec92869270b7b7e02aa0f0b8545fbae01">
                             Relist for transplant if no improvement&nbsp;
                        </li>
                    </ul>
                </td>
            </tr>
        </tbody>
    </table>
</figure>
      </div>
    </div>
  </div>
</div>
